Match tier Listed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-08
Juan Carlos Rico profile photo

Juan Carlos Rico

Associate Professor

Also affiliated: Northwell Health (2015); Hofstra University (2015); University of South Florida (2019); University of Arkansas Medical Center (2018); Office of Infectious Diseases (2017); Florida College (2019)

Faculty Researcher

Internal Med, College of Medicine

8 h-index 39 pubs 263 cited

  • Humans
  • Fusariosis
  • Male
  • Immunocompromised Host
  • Antifungal Agents
  • Retrospective Studies
  • Voriconazole
  • Anti-Infective Agents
  • Bacteremia
  • Blood Transfusion
  • Fatal Outcome
  • Multiple Myeloma
  • Aged
  • Microbial Sensitivity Tests
  • Itraconazole

Biography and Research Information

OverviewAI-generated summary

Juan Carlos Rico's research focuses on infectious diseases and immunocompromised hosts, particularly in the context of hematologic malignancies. He has investigated the use of antifungal agents like rezafungin for invasive candidiasis and has published case reports and series on fungal infections, including histoplasmosis in HIV patients. His work also examines the impact of infections and treatments on specific patient populations, such as multiple myeloma patients undergoing autologous stem cell transplant and the immunogenicity of COVID-19 vaccines in this group. Rico's research extends to understanding survival factors following COVID-19 infection in transplant recipients, considering variables like transplant type, age, and immunosuppression levels. He has also conducted systematic literature reviews on topics such as risk factors for sudden unexpected death in epilepsy. Rico holds an h-index of 8 with 39 publications and 259 citations, and he actively collaborates with colleagues at the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 8
  • Publications: 39
  • Citations: 263

Selected Publications

  • A cautionary tale of false-positive histoplasma urine antigen in an HIV patient: a case report (2025)
    Access Microbiology DOI OpenAlex
  • A Cautionary Tale of False Positive Histoplasma Urine Antigen in an HIV Patient: A Case Report (2025)
  • It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis (2025)
    Infectious Diseases and Therapy 10 citations DOI OpenAlex
  • A Cautionary Tale of False Positive Histoplasma Urine Antigen in an HIV Patient: A Case Report (2024)
  • Do high MICs predict the outcome in invasive fusariosis? (2020)
    Journal of Antimicrobial Chemotherapy 59 citations DOI OpenAlex
  • Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients (2020)
    Clinical Infectious Diseases 47 citations DOI OpenAlex
  • Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? (2019)
    Mycoses 23 citations DOI OpenAlex
  • Infectious and immunological sequelae of daratumumab in multiple myeloma (2018)
    British Journal of Haematology 44 citations DOI OpenAlex
  • An Enlarging Lung Nodule in an Immunocompromised Host (2017)
    Clinical Infectious Diseases DOI OpenAlex
  • A Quality Improvement project to decrease overuse of vancomycin in an inpatient Hematology/Oncology service. (2016)
    Journal of Clinical Oncology 1 citation DOI OpenAlex
  • <i>Lasiodiplodia</i> species fungal osteomyelitis in a multiple myeloma patient (2016)
    Transplant Infectious Disease 8 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

11 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics